RxDoctor Payments Data

Ashley Gattis, NP

Nurse Practitioner · Clarksville, ARNPI 1063932283

Payments from drug & device makers

$1,208in general payments, 2019–2025

Across 83 payments — averaging $14.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$278
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$229
  • AstraZeneca$135
  • GSK$107
  • Abbott$84
  • Lilly USA, LLC$54
  • plus $322 from 14 others

What the payments were for

  • Food & beverage$1,208100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,208 in reported general payments places this provider in the 75th percentile of 697 nurse practitioner providers in Arkansas.

See all nurse practitioner providers in Arkansas

Medicare billing

Part B allowed, 2024
$5,921
Medicare patients
156
Services billed
310

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol77$67,616
OzempicSemaglutide32$40,298
MounjaroTirzepatide34$36,276
Trelegy ElliptaFluticasone/Umeclidin/Vilanter46$34,244
Breztri AerosphereBudesonide/Glycopyr/Formoterol40$25,361
JanuviaSitagliptin Phosphate30$20,444
XareltoRivaroxaban32$16,394
EliquisApixaban18$12,627
JardianceEmpagliflozin13$9,149
GemtesaVibegron21$7,969
Spiriva RespimatTiotropium Bromide12$6,527
Lantus SolostarInsulin Glargine,hum.Rec.Anlog29$4,381
SymbicortBudesonide/Formoterol Fumarate11$4,292
Gabapentin218$2,876
Albuterol Sulfate HfaAlbuterol Sulfate107$2,812

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$135$97,269128 claims
Novo NordiskOzempic$34$40,29832 claims
Lilly USA, LLCMounjaro$54$36,27634 claims
GSKTrelegy Ellipta$107$34,24446 claims
Johnson & JohnsonXarelto$25$16,39432 claims
Sumitomo Pharma America, Inc.Gemtesa$17$7,96921 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 697 nurse practitioner providers in Arkansas.

Other nurse practitioner in Clarksville

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →